Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aurora Europe
Berlin, Germanyauroramedicine.com ↗
- Ownership
- Private
- Employees
- ~260
- Development stage
- Other
01
Overview
Aurora Europe is the leading importer and distributor of EU-GMP pharmaceutical grade medical cannabis in continental Europe, with commercial sales in Germany, the UK, France, Poland, Italy, and other EU markets. Aurora’s clinical activity includes partnerships with local healthcare and pilot programs; their products are used for treating chronic pain, spasticity, and other indications. Aurora Europe holds important government supply contracts including the French pilot program and nationwide supply contracts in Italy and Luxembourg.[5][6]
- Therapeutic areas
- OncologyGastroenterologyNeurology
- Modalities
- Plant-derived medicineSmall molecule
- Industry
- Biotech
02
Partnerships
Ethypharm (France government pilot supply)Wholesale/distribution partners in Germany, Poland, UK, and other EU countries
Beyond the preview
Go deeper on Aurora Europe.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aurora Europe.